Why the study?
Do clinical characteristics and outcomes, including mortality, differ between transcatheter and surgical bioprostheses in patients with aortic prosthetic valve endocarditis?
Do clinical characteristics and outcomes, including mortality, differ between transcatheter and surgical bioprostheses in patients with aortic prosthetic valve endocarditis?
Despite undergoing surgery less frequently when indicated, patients with TAVI-associated infective endocarditis have similar in-hospital and 1-year mortality compared to those with SAVR-associated endocarditis.
Answers are grounded in this paper and cite their sources.
Similar mortality despite less surgery in IE-TAVI; leaves open optimal surgical thresholds for TAVI endocarditis.
Patients with IE-TAVI had a higher incidence of early prosthetic valve IE. Compared to IE-SAVR, IE-TAVI patients underwent cardiac surgery much less frequently, despite having surgical indications. However, in-hospital and 1-year mortality rate was similar between both groups.
No takes yet. Share an insight, caveat, or question.
Jerónimo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: